STRUCTURAL INSIGHTS FOR TWO FAB–ANTIGEN COMPLEXES:
Platelet glycoprotein VI and SARS-CoV-2 receptor binding domain
Platelet glycoprotein VI (GPVI) is a potential target for the development of new
antiplatelet molecules with low bleeding risk. GPVI binding to vascular collagen initiates
thrombus formation and GPVI interactions with fibrin stimulate the growth and stability
of the thrombus.
The study demonstrates that Glenzocimab inhibits GPVI interactions with both ligands
by loss of dimerization, conformational changes, and steric hindrance.
• The crystal structure of Glenzocimab with the monomeric extracellular domain of
GPVI was determined to 1.9 Å.
• The crystal structure shows that Glenzocimab binds to the site of dimerization in the
D2 domain of GPVI.
• Glenzocimab inhibits GPIV interaction with CRP, collagen and fibrin by loss of
dimerization, conformational changes and steric hindrance.
AUTHORS: NADIA ROSE, DOROTA FOCHT, MARTIN WELIN AND RAYMOND KIMBUNG
Nadia Rose, Line Manager
nadia.rose@saromics.com
Contact
Platelet glycoprotein VI
SARS-CoV-2 receptor binding domain
The SARS-CoV-2 pandemic has been a major public health issue
worldwide. Although the population has widely received vaccination
against SARS-CoV-2, immunocompromised patients can still be
susceptible to infection.
The study demonstrates how two different hmAbs (1D1 and 3D2)
that showed high binding activity to the RBD of SARS-CoV-2 could
be used against multiple variants of the virus and provide
therapeutic benefits to COVID-19 patients.
• We determined the structures of
• 1D1 Fab – RBD complex to 1.9 Å
• 3D2 Fab – RBD (beta variant) complex to 2.2 Å
• Pseudovirion-based neutralization results showed that the
antibody cocktail of 1D1 and 3D2 showed high potency in
multiple variants of SARS-CoV-2 infection.
• The results illustrate the potential of this cocktail as an
intervention against SARS-CoV-2 infection.
• In vivo studies showed the ability of the antibody cocktail
treatment to reduce viral load (beta variant) in blood and various
tissues.
Reference: Boonkrai C, Cotrone TS, Chaisuriyong W, Tantawichien T, Thisyakorn U, Fernandez S, Hunsawong T, Reed M,
Wongtangprasert T, Audomsun T, Phakham T, Attakitbancha C, Saelao P, Focht D, Kimbung R, Welin M, Malik AA, Pisitkun T,
Srisawat N. PLoS One 2023 May 4;18(5):e0284173.
Reference: Billiald P, Slater A, Welin M, Clark JC, Loyau S, Pugnière M, Jiacomini IG, Rose N, Lebozec K, Toledano E, François
D, Watson SP, Jandrot-Perrus M. Blood Adv. 2023 Apr 11;7(7):1258-1268.
D1
D2
LC
HC
D1
D2
A) Dimerization of GPVI (PDB ID 2GI7) colored in green and magenta. B) Superimposition of
monomeric GPVI domain D2 (yellow) revealing conformational changes that disrupt the dimerization.
Same color scheme as in A.
GPVI –D2
GPVI –D2 GPVI –D2
When Glenzocimab binds to domain D2 of GPVI, there is a rearrangement in a loop
region. This loop changes conformation and part of the loop forms a β-strand that
extends the β-sheet. The extended β-sheet disrupts the formation of a dimer.
A B
A B
A) Complex of Glenzocimab – GPVI. B) Superimpostion of one molecule of dimeric GPVI (PDB ID 2GI7) with GPVI from
the Glenzocimab – GPVI complex.
Mode of action

More Related Content

PDF
STRUCTURAL INSIGHTS FOR TWO FAB–ANTIGEN COMPLEXES: Platelet glycoprotein VI a...
PPT
224 k ras polymorphism in cancer, for atherosclerosis
PPT
224 k ras polymorphism in cancer, for atherosclerosis
PDF
Book spike sars-cov-2 as procoagulant factor and vaccine class effect hypoth...
PDF
Gomathi_JPAM_Vol_16_Issue3_p_1595-1607.pdf
PDF
Role of the c8orf13 blk
PDF
Rheumatoid arthritis
STRUCTURAL INSIGHTS FOR TWO FAB–ANTIGEN COMPLEXES: Platelet glycoprotein VI a...
224 k ras polymorphism in cancer, for atherosclerosis
224 k ras polymorphism in cancer, for atherosclerosis
Book spike sars-cov-2 as procoagulant factor and vaccine class effect hypoth...
Gomathi_JPAM_Vol_16_Issue3_p_1595-1607.pdf
Role of the c8orf13 blk
Rheumatoid arthritis

Similar to STRUCTURAL INSIGHTS FOR TWO FAB–ANTIGEN COMPLEXES: Platelet glycoprotein VI and SARS-CoV-2 receptor binding domain (20)

PPTX
atypical lymphocytes in dengue.pptx
PPTX
anti vegf.pptx
PDF
blood
PDF
FoulkesLi2015-PMS2_founder_mismatch_repair
PDF
ALTERACIONES EN LA DISFUNCION MULTIORGANICA.pdf
PDF
Thesis_Ladan_Mansouri
PDF
Osmf rnk
PDF
PDF
IGF2BP3 Is Associated with HPV Status and Tight Junction in HPV-Related Cervi...
PDF
IGF2BP3 Is Associated with HPV Status and Tight Junction in HPV-Related Cervi...
PDF
IGF2BP3 Is Associated with HPV Status and Tight Junction in HPV-Related Cervi...
PDF
Plasma Exchange and Glucocrticoids.NEJM.pdf
PDF
cao2008.pdf
PDF
Identification of the Enrichment Pathways of Catalase in Multiple Primary Tumors
PDF
Graft versus-host disease
PDF
Proteomics Exploration of Chronic Lymphocytic Leukemia_Crimson Publishers
PDF
Overview of platelet physiology
PPTX
Periodontal medicine.pptx
PPTX
Hypertension and HTPR (high on treatment platelet reactivity measured by aggr...
atypical lymphocytes in dengue.pptx
anti vegf.pptx
blood
FoulkesLi2015-PMS2_founder_mismatch_repair
ALTERACIONES EN LA DISFUNCION MULTIORGANICA.pdf
Thesis_Ladan_Mansouri
Osmf rnk
IGF2BP3 Is Associated with HPV Status and Tight Junction in HPV-Related Cervi...
IGF2BP3 Is Associated with HPV Status and Tight Junction in HPV-Related Cervi...
IGF2BP3 Is Associated with HPV Status and Tight Junction in HPV-Related Cervi...
Plasma Exchange and Glucocrticoids.NEJM.pdf
cao2008.pdf
Identification of the Enrichment Pathways of Catalase in Multiple Primary Tumors
Graft versus-host disease
Proteomics Exploration of Chronic Lymphocytic Leukemia_Crimson Publishers
Overview of platelet physiology
Periodontal medicine.pptx
Hypertension and HTPR (high on treatment platelet reactivity measured by aggr...
Ad

Recently uploaded (20)

PPT
Comm.-100W-Writing-a-Convincing-Editorial-slides.ppt
PPTX
export_1a21b709-15ab-43fc-88b3-50ecde18572d.pptx
PDF
The History of COBSI, a Community-based Smallholder Irrigation, and its Regio...
PPTX
The Power of Communication & Overcoming
PDF
Building event-driven application with RAP Business Events in ABAP Cloud
PPTX
2025-08-17 Joseph 03 (shared slides).pptx
PPTX
Basics of Stereotypes and Prejudice(1).pptx
PDF
Books and book chapters(CITATIONS AND REFERENCING) (LORENA).pdf
PPTX
Ulangan Harian_TEOREMA PYTHAGORAS_8.pptx
PDF
Pitch Style Data Report Template Preview
PPTX
Lesson-4-MS-Word-Inserting-Editing-Formatting-Objects.pptx.pptx
PDF
Echoes of AccountabilityComputational Analysis of Post-Junta Parliamentary Qu...
PDF
Criminology Midterm-Ed Gein Presentation
PDF
Ch-5.pdf important formulas requires for class 12
PPTX
Ruth Week 1 - Hope in Barren Places.pptx
PPTX
History Subject for High School_ Military Dictatorships by Slidesgo.pptx
PPTX
HRPTA PPT 2024-2025 FOR PTA MEETING STUDENTS
PPTX
Presentacion lugares conocidos ingles sena.pptx
PPTX
Challenges, strengths and prospects of Pakistan in.pptx
PPTX
The walking dead SERIE PARA EXPONER DISPOSITIVA
Comm.-100W-Writing-a-Convincing-Editorial-slides.ppt
export_1a21b709-15ab-43fc-88b3-50ecde18572d.pptx
The History of COBSI, a Community-based Smallholder Irrigation, and its Regio...
The Power of Communication & Overcoming
Building event-driven application with RAP Business Events in ABAP Cloud
2025-08-17 Joseph 03 (shared slides).pptx
Basics of Stereotypes and Prejudice(1).pptx
Books and book chapters(CITATIONS AND REFERENCING) (LORENA).pdf
Ulangan Harian_TEOREMA PYTHAGORAS_8.pptx
Pitch Style Data Report Template Preview
Lesson-4-MS-Word-Inserting-Editing-Formatting-Objects.pptx.pptx
Echoes of AccountabilityComputational Analysis of Post-Junta Parliamentary Qu...
Criminology Midterm-Ed Gein Presentation
Ch-5.pdf important formulas requires for class 12
Ruth Week 1 - Hope in Barren Places.pptx
History Subject for High School_ Military Dictatorships by Slidesgo.pptx
HRPTA PPT 2024-2025 FOR PTA MEETING STUDENTS
Presentacion lugares conocidos ingles sena.pptx
Challenges, strengths and prospects of Pakistan in.pptx
The walking dead SERIE PARA EXPONER DISPOSITIVA
Ad

STRUCTURAL INSIGHTS FOR TWO FAB–ANTIGEN COMPLEXES: Platelet glycoprotein VI and SARS-CoV-2 receptor binding domain

  • 1. STRUCTURAL INSIGHTS FOR TWO FAB–ANTIGEN COMPLEXES: Platelet glycoprotein VI and SARS-CoV-2 receptor binding domain Platelet glycoprotein VI (GPVI) is a potential target for the development of new antiplatelet molecules with low bleeding risk. GPVI binding to vascular collagen initiates thrombus formation and GPVI interactions with fibrin stimulate the growth and stability of the thrombus. The study demonstrates that Glenzocimab inhibits GPVI interactions with both ligands by loss of dimerization, conformational changes, and steric hindrance. • The crystal structure of Glenzocimab with the monomeric extracellular domain of GPVI was determined to 1.9 Å. • The crystal structure shows that Glenzocimab binds to the site of dimerization in the D2 domain of GPVI. • Glenzocimab inhibits GPIV interaction with CRP, collagen and fibrin by loss of dimerization, conformational changes and steric hindrance. AUTHORS: NADIA ROSE, DOROTA FOCHT, MARTIN WELIN AND RAYMOND KIMBUNG Nadia Rose, Line Manager [email protected] Contact Platelet glycoprotein VI SARS-CoV-2 receptor binding domain The SARS-CoV-2 pandemic has been a major public health issue worldwide. Although the population has widely received vaccination against SARS-CoV-2, immunocompromised patients can still be susceptible to infection. The study demonstrates how two different hmAbs (1D1 and 3D2) that showed high binding activity to the RBD of SARS-CoV-2 could be used against multiple variants of the virus and provide therapeutic benefits to COVID-19 patients. • We determined the structures of • 1D1 Fab – RBD complex to 1.9 Å • 3D2 Fab – RBD (beta variant) complex to 2.2 Å • Pseudovirion-based neutralization results showed that the antibody cocktail of 1D1 and 3D2 showed high potency in multiple variants of SARS-CoV-2 infection. • The results illustrate the potential of this cocktail as an intervention against SARS-CoV-2 infection. • In vivo studies showed the ability of the antibody cocktail treatment to reduce viral load (beta variant) in blood and various tissues. Reference: Boonkrai C, Cotrone TS, Chaisuriyong W, Tantawichien T, Thisyakorn U, Fernandez S, Hunsawong T, Reed M, Wongtangprasert T, Audomsun T, Phakham T, Attakitbancha C, Saelao P, Focht D, Kimbung R, Welin M, Malik AA, Pisitkun T, Srisawat N. PLoS One 2023 May 4;18(5):e0284173. Reference: Billiald P, Slater A, Welin M, Clark JC, Loyau S, Pugnière M, Jiacomini IG, Rose N, Lebozec K, Toledano E, François D, Watson SP, Jandrot-Perrus M. Blood Adv. 2023 Apr 11;7(7):1258-1268. D1 D2 LC HC D1 D2 A) Dimerization of GPVI (PDB ID 2GI7) colored in green and magenta. B) Superimposition of monomeric GPVI domain D2 (yellow) revealing conformational changes that disrupt the dimerization. Same color scheme as in A. GPVI –D2 GPVI –D2 GPVI –D2 When Glenzocimab binds to domain D2 of GPVI, there is a rearrangement in a loop region. This loop changes conformation and part of the loop forms a β-strand that extends the β-sheet. The extended β-sheet disrupts the formation of a dimer. A B A B A) Complex of Glenzocimab – GPVI. B) Superimpostion of one molecule of dimeric GPVI (PDB ID 2GI7) with GPVI from the Glenzocimab – GPVI complex. Mode of action